What We're Reading: Page 293
Industry reads hand-picked by our editors
Sep 08, 2017
Sep 07, 2017
Sep 06, 2017
-
Financial Times
Secretive Moderna yet to convince on $5bn valuation
-
Forbes
New blood needed: Pharma R&D leadership tenure
-
The Wall Street Journal
Don’t ignore big pharma’s new breakthrough
Sep 05, 2017
-
The Wall Street Journal
Takeda Pharmaceutical Prescribes Stability After Rough Start
-
The New York Times
Opioids Aren’t the Only Pain Drugs to Fear
-
Reuters
Medical device maker Teleflex to buy NeoTract in $1.1 billion deal
Sep 01, 2017
Aug 31, 2017
Aug 30, 2017
-
Financial Times
Open borders key to Swiss pharma’s EU success
-
Bloomberg
ETF investors arrive just in time to get a slice of an $11.9 billion biotech deal
-
The San Diego Union-Tribune
Green card policy change could affect San Diego biotech companies